369 related articles for article (PubMed ID: 24840262)
1. Lipids and lipid management in diabetes.
Jaiswal M; Schinske A; Pop-Busui R
Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):325-38. PubMed ID: 24840262
[TBL] [Abstract][Full Text] [Related]
2. Statins and diabetes.
Carmena R; Betteridge DJ
Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis and management of the dyslipidemia of the metabolic syndrome.
Raal FJ
Metab Syndr Relat Disord; 2009 Apr; 7(2):83-8. PubMed ID: 19400742
[TBL] [Abstract][Full Text] [Related]
4. Combination lipid therapy in type 2 diabetes mellitus.
Vergès B
Expert Opin Pharmacother; 2011 Jun; 12(9):1393-403. PubMed ID: 21323502
[TBL] [Abstract][Full Text] [Related]
5. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
6. Targeting cardiovascular risk in patients with diabetes: management of dyslipidemia.
Ali YS; Linton MF; Fazio S
Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):142-6. PubMed ID: 18316949
[TBL] [Abstract][Full Text] [Related]
7. Diabetic Dyslipidemia Review: An Update on Current Concepts and Management Guidelines of Diabetic Dyslipidemia.
Dake AW; Sora ND
Am J Med Sci; 2016 Apr; 351(4):361-5. PubMed ID: 27079341
[TBL] [Abstract][Full Text] [Related]
8. Treatment of diabetic dyslipoproteinemia.
Steinmetz A
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):239-45. PubMed ID: 12951627
[TBL] [Abstract][Full Text] [Related]
9. Diabetic dyslipidemia: extending the target beyond LDL cholesterol.
Nicholls SJ; Lundman P; Tardif JC
Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S20-4. PubMed ID: 20489416
[TBL] [Abstract][Full Text] [Related]
10. Pattern of dyslipidemia and evaluation of non-HDL cholesterol as a marker of risk factor for cardiovascular disease in type 2 diabetes mellitus.
Pandeya A; Sharma M; Regmi P; Basukala A; Lamsal M
Nepal Med Coll J; 2012 Dec; 14(4):278-82. PubMed ID: 24579534
[TBL] [Abstract][Full Text] [Related]
11. The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia.
Fruchart JC; Sacks F; Hermans MP; Assmann G; Brown WV; Ceska R; Chapman MJ; Dodson PM; Fioretto P; Ginsberg HN; Kadowaki T; Lablanche JM; Marx N; Plutzky J; Reiner Z; Rosenson RS; Staels B; Stock JK; Sy R; Wanner C; Zambon A; Zimmet P
Am J Cardiol; 2008 Nov; 102(10 Suppl):1K-34K. PubMed ID: 19068318
[TBL] [Abstract][Full Text] [Related]
12. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
Rader DJ
Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
[TBL] [Abstract][Full Text] [Related]
13. New insights into the pathophysiology of dyslipidemia in type 2 diabetes.
Taskinen MR; Borén J
Atherosclerosis; 2015 Apr; 239(2):483-95. PubMed ID: 25706066
[TBL] [Abstract][Full Text] [Related]
14. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
Oki JC
Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic management of isolated low high-density lipoprotein syndrome.
Bermúdez V; Cano R; Cano C; Bermúdez F; Arraiz N; Acosta L; Finol F; Pabón MR; Amell A; Reyna N; Hidalgo J; Kendall P; Manuel V; Hernández R
Am J Ther; 2008; 15(4):377-88. PubMed ID: 18645343
[TBL] [Abstract][Full Text] [Related]
16. Lipid and lipoprotein profiles in Ethiopian patients with diabetes mellitus.
Siraj ES; Seyoum B; Saenz C; Abdulkadir J
Metabolism; 2006 Jun; 55(6):706-10. PubMed ID: 16713427
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and association with diabetes and obesity of lipid phenotypes among the hypertensive Chinese rural adults.
Zhang X; Sun Z; Zhang D; Zheng L; Li J; Liu S; Xu C; Li J; Hu D; Sun Y
Heart Lung; 2009; 38(1):17-24. PubMed ID: 19150527
[TBL] [Abstract][Full Text] [Related]
18. [Lipid management--treatment goal and strategy].
Koshiyama H
Nihon Rinsho; 2006 Nov; 64(11):2102-6. PubMed ID: 17087303
[TBL] [Abstract][Full Text] [Related]
19. Dyslipidemia in the metabolic syndrome in children.
Gidding SS
J Cardiometab Syndr; 2006; 1(4):282-5. PubMed ID: 17679808
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic approach to dyslipidemia and goal achievement in a Spanish population with type 2 diabetes without cardiovascular disease].
Pérez A; González Blanco C; Hernández-Presa MÁ; Chaves J
Endocrinol Nutr; 2011; 58(6):283-90. PubMed ID: 21641286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]